Stocktoria
Enovis CORP ENOV
NYSE · XNYS · stock · Orthopedic, Prosthetic & Surgical Appliances & Supplies · website · IPO 2008-05-08
Enovis CORP financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $2.2B | $2.1B | $1.7B | $1.6B | $1.4B |
| Gross profit | $1.3B | $1.2B | $990.8M | $869.4M | $777.7M |
| R&D expense | $120.3M | $91.3M | $75.3M | $60.8M | $49.1M |
| SG&A expense | $1.1B | $1.0B | $830.3M | $772.9M | $665.8M |
| Operating income | -$1.1B | -$775.7M | -$65.7M | -$71.2M | -$62.8M |
| Interest expense | $34.8M | $57.1M | $19.7M | $24.1M | $29.1M |
| Income tax | $22.3M | $4.5M | -$13.3M | $36.1M | -$19.5M |
| Net income | -$1.2B | -$825.5M | -$33.3M | -$13.3M | $71.7M |
| EPS (diluted) | $-20.75 | $-14.93 | $-0.61 | $-0.25 | $1.40 |
| Operating cash flow | $217.3M | $113.5M | $135.0M | -$55.9M | $356.1M |
| Free cash flow | $19.9M | -$67.2M | $12.8M | -$161.3M | $251.9M |
| Cash & equivalents | $36.4M | $48.2M | $36.2M | $24.3M | $680.3M |
| Inventory | $584.4M | $547.1M | $468.8M | $426.6M | $356.2M |
| Total assets | $3.8B | $4.7B | $4.5B | $4.3B | $8.5B |
| Total liabilities | $2.3B | $2.2B | $1.1B | $823.4M | $3.9B |
| Shareholders' equity | $1.5B | $2.6B | $3.4B | $3.4B | $4.7B |
Source: SEC EDGAR filings · CIK 0001420800 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.